Based on these data, the FDA approved tesamorelin (marketed as EGRIFTA) for the reduction of excess abdominal fat in HIVassociated lipodystrophy, not as a general weightloss drug for the wider population. Tesamorelin Risks and Considerations Like all hormonemodulating therapies, tesamorelin carries potential risks, including fluid retention, joint pain, injectionsite reactions, and effects on glucose metabolism in susceptible patients
Shots of vitamin B12 are often given in doses of 1,000 mcg/mL, while vitamin B12 pills often come in capsules, tablets, or soft gels of 50 to 5,000 mcg
Always consult your healthcare provider before starting any new supplement regimen.
Many patients feel that benefit quickly, especially if they have been running low